메뉴 건너뛰기




Volumn 40, Issue 6, 2007, Pages 291-292

Neuroleptic treatment of alcohol hallucinosis: Case series [3]

Author keywords

[No Author keywords available]

Indexed keywords

FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

EID: 36849088235     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992144     Document Type: Letter
Times cited : (9)

References (21)
  • 1
    • 30344436336 scopus 로고    scopus 로고
    • Application of glycine in acute alcohol hallucinosis
    • Aliyev NA, Aliyev ZN. Application of glycine in acute alcohol hallucinosis. Human Psychopharmacol 2005; 20: 591-594
    • (2005) Human Psychopharmacol , vol.20 , pp. 591-594
    • Aliyev, N.A.1    Aliyev, Z.N.2
  • 2
    • 36849027202 scopus 로고    scopus 로고
    • Methodik und Dokumentation in der Psychiatrie/AMDP
    • 5th revised edn. Göttingen, Bern, Berlin, Heidelberg, New York, Hogrefe
    • Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie/AMDP. Das AMDP-System: Manual zur Dokumentation psychiatrischer Befunde 5th revised edn. Göttingen, Bern, Berlin, Heidelberg, New York, Hogrefe, 2005
    • (2005) Das AMDP-System: Manual zur Dokumentation psychiatrischer Befunde
    • Arbeitsgemeinschaft für1
  • 3
    • 0022639431 scopus 로고
    • Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents
    • Borg S, Kvande H, Valverius P. Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents. Psychopharmacology 1986; 88: 12
    • (1986) Psychopharmacology , vol.88 , pp. 12
    • Borg, S.1    Kvande, H.2    Valverius, P.3
  • 4
    • 13244249917 scopus 로고    scopus 로고
    • Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses
    • Caton CLM, Drake RE, Hasin D, Dominguez B, Shrout PE, Samet S, Schanzer B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry 2005; 62: 137-145
    • (2005) Arch Gen Psychiatry , vol.62 , pp. 137-145
    • Caton, C.L.M.1    Drake, R.E.2    Hasin, D.3    Dominguez, B.4    Shrout, P.E.5    Samet, S.6    Schanzer, B.7
  • 5
    • 34347381074 scopus 로고    scopus 로고
    • Treatment of alcohol hallucinosis with risperidone
    • De Millas W, Haasen C. Treatment of alcohol hallucinosis with risperidone. Am J Addict 2007; 16: 249-250
    • (2007) Am J Addict , vol.16 , pp. 249-250
    • De Millas, W.1    Haasen, C.2
  • 6
    • 0024504232 scopus 로고
    • Effects of spontaneous ingestion of ethanol on brain dopamine metabolism
    • Fadda F, Mosca E, Colombo G, Gessa GL. Effects of spontaneous ingestion of ethanol on brain dopamine metabolism. Life Sci 1989; 44: 281
    • (1989) Life Sci , vol.44 , pp. 281
    • Fadda, F.1    Mosca, E.2    Colombo, G.3    Gessa, G.L.4
  • 7
    • 0024517916 scopus 로고
    • Alcohol hallucinosis: A psychiatric enigma - 1. the development of an idea
    • Glass IB. Alcohol hallucinosis: a psychiatric enigma - 1. the development of an idea. Br J Addiction 1989; 84: 29-41
    • (1989) Br J Addiction , vol.84 , pp. 29-41
    • IB, G.1
  • 8
    • 0024505670 scopus 로고
    • Alcohol hallucinosis: A psychiatric enigma - 2. the follow-up studies
    • Glass IB. Alcohol hallucinosis: a psychiatric enigma - 2. the follow-up studies. Br J Addict 1989; 84: 151-164
    • (1989) Br J Addict , vol.84 , pp. 151-164
    • IB, G.1
  • 10
    • 2442560048 scopus 로고    scopus 로고
    • Provoked recurrence of alcohol hallucinosis - remission with additive amisulpride medication. A case report
    • Hermann D, Heinz A, Croissant B, Mann K. Provoked recurrence of alcohol hallucinosis - remission with additive amisulpride medication. A case report. Pharmacopsychiatry 2004; 37: 90-92
    • (2004) Pharmacopsychiatry , vol.37 , pp. 90-92
    • Hermann, D.1    Heinz, A.2    Croissant, B.3    Mann, K.4
  • 12
    • 0025317496 scopus 로고
    • Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia
    • Soyka M. Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia. Acta Psychiatrica Scandinavica 1990; 81: 255-259
    • (1990) Acta Psychiatrica Scandinavica , vol.81 , pp. 255-259
    • Soyka, M.1
  • 13
    • 0026565248 scopus 로고
    • Neuroleptic treatment in alcohol hallucinosis: No evidence for increased seizure risk
    • Soyka M, Botschev C, Völcker A. Neuroleptic treatment in alcohol hallucinosis: no evidence for increased seizure risk. J Clin Psychopharmacol 1992; 12: 66-67
    • (1992) J Clin Psychopharmacol , vol.12 , pp. 66-67
    • Soyka, M.1    Botschev, C.2    Völcker, A.3
  • 14
    • 0028969030 scopus 로고
    • Pathophysiologic mechanisms possibly involved in the development of alcohol hallucinosis
    • Soyka M. Pathophysiologic mechanisms possibly involved in the development of alcohol hallucinosis. Addiction 1995; 90: 289-290
    • (1995) Addiction , vol.90 , pp. 289-290
    • Soyka, M.1
  • 15
    • 0030762367 scopus 로고    scopus 로고
    • Risperidone in treatment-refractory chronic alcohol hallucinosis
    • Soyka M, Wegner U, Moeller H-J. Risperidone in treatment-refractory chronic alcohol hallucinosis. Pharmacopsychiatry 1997; 30: 135-136
    • (1997) Pharmacopsychiatry , vol.30 , pp. 135-136
    • Soyka, M.1    Wegner, U.2    Moeller, H.-J.3
  • 16
    • 0034309743 scopus 로고    scopus 로고
    • PET and SPECT findings in alcohol hallucinosis: Case report and super-brief review of the pathophysiology of this syndrome
    • Soyka M Dresel S, Horak M, Rüther T, Tatsch K. PET and SPECT findings in alcohol hallucinosis: Case report and super-brief review of the pathophysiology of this syndrome. World J Biol Psychiatry 2000; 1: 215-218
    • (2000) World J Biol Psychiatry , vol.1 , pp. 215-218
    • Soyka, M.1    Dresel, S.2    Horak, M.3    Rüther, T.4    Tatsch, K.5
  • 17
    • 0034067622 scopus 로고    scopus 로고
    • FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis
    • Soyka M, Zetzsche T, Dresel S, Tatsch K. FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci 2000; 12: 287-288
    • (2000) J Neuropsychiatry Clin Neurosci , vol.12 , pp. 287-288
    • Soyka, M.1    Zetzsche, T.2    Dresel, S.3    Tatsch, K.4
  • 18
    • 23644441750 scopus 로고    scopus 로고
    • Thalamic hypofunction in alcohol hallucinosis: FDG PET findings
    • Soyka M, Koch W, Tatsch K. Thalamic hypofunction in alcohol hallucinosis: FDG PET findings. Psychiatry Res Neuroimaging 2005; 30: 259-262
    • (2005) Psychiatry Res Neuroimaging , vol.30 , pp. 259-262
    • Soyka, M.1    Koch, W.2    Tatsch, K.3
  • 19
    • 0018906805 scopus 로고
    • Alcoholic hallucinosis: A missed diagnosis
    • Surawicz FG. Alcoholic hallucinosis: a missed diagnosis. Can J Psychiatry 1980; 25: 57-63
    • (1980) Can J Psychiatry , vol.25 , pp. 57-63
    • FG, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.